5 - Update on COVID-19 Diagnostics

Wednesday, October 19, 2022

1:30 PM – 3:15 PM US ET

Location: 146 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Nira Pollock, MD, PhD

Associate Medical Director, Infectious Diseases Diagnostic Lab/Associate Professor of Pathology and Medicine
Boston Children's Hospital
Boston, Massachusetts, United States

Disclosure(s): No financial relationships to disclose
Elitza Theel, PhD, D(ABMM)

Director, Infectious Diseases Serology Laboratory
Laboratory Medicine and Pathology
Mayo Clinic
Rochester, Minnesota, United States

Disclosure(s): Euroimmun US: Advisor/Consultant (); Oxford Immunotech: Advisor/Consultant (); Roche Diagnostics: Advisor/Consultant (); Serimmune Inc: Advisor/Consultant ()

Slides

Faculty(s)

Bruce Tromberg, PhD

Director
National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health
Imaging, MD, United States

Disclosure(s): No financial relationships to disclose

Slides
Elitza Theel, PhD, D(ABMM)

Director, Infectious Diseases Serology Laboratory
Laboratory Medicine and Pathology
Mayo Clinic
Rochester, Minnesota, United States

Disclosure(s): Euroimmun US: Advisor/Consultant (); Oxford Immunotech: Advisor/Consultant (); Roche Diagnostics: Advisor/Consultant (); Serimmune Inc: Advisor/Consultant ()

Slides
Christina Silcox, PhD (she/her/hers)

Research Director
Duke-Margolis Center for Health Policy
Washington, DC, United States

Disclosure(s): No financial relationships to disclose

Slides

Disclosure(s):

Nira R. Pollock, MD, PhD: No financial relationships to disclose

Elitza Theel, PhD, D(ABMM): Euroimmun US: Advisor/Consultant (); Oxford Immunotech: Advisor/Consultant (); Roche Diagnostics: Advisor/Consultant (); Serimmune Inc: Advisor/Consultant ()

Bruce Tromberg, PhD: No financial relationships to disclose

Christina Silcox, PhD: No financial relationships to disclose

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.75 hours of MOC Credit
CNE Credits: Maximum of 1.75 hours of ANCC Credit
ACPE Credits: ACPE 1.75 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

review challenges and opportunities related to home testing for COVID-19, including performance criteria, use cases and results reporting;
recognize the structure, process and impact of the NIH Rapid Acceleration of Diagnostics (RADx) initiative and how COVID-19 tests are being evaluated/re-evaluated in the face of emerging variants;
summarize performance and use cases for available COVID-19 serologic assays

Presentations:

1:30 PM – 2:05 PM US ET

Testing for COVID-19 at Home: Challenges and Opportunities
Speaker: Christina Silcox, PhD (she/her/hers) – Duke-Margolis Center for Health Policy
2:05 PM – 2:40 PM US ET

Bioengineering for COVID-19: Rapid Acceleration of Diagnostics Technology (RADx Tech) at Unprecedented Speed and Scale
Speaker: Bruce Tromberg, PhD – National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health
2:40 PM – 3:15 PM US ET

Serologic Testing for COVID-19: Is There a Use Case Now?
Speaker: Elitza Theel, PhD, D(ABMM) – Mayo Clinic